Introduction
============

Epithelial and endothelial cells serve as sentries in most of the living systems by providing protective barriers to the various organs from their surroundings and help maintaining homeostasis ([@B61]; [@B129]; [@B34]). These protective barriers are categorized as tight junctions (TJs), adherens junctions (AJs), and desmosomes. Proteins in the TJ barrier are mainly involved in regulation of intercellular communication and paracellular transport ([@B1]). Based on their functions they are classified as anchoring junctions, gap junctions and TJ proteins.

Cell adhesion to the extracellular-matrix is vital for normal cell functioning and proper adhesion is thought to be prerequisite for optimal function of cell surface receptors. Anchoring junction proteins including cadherins, catenins, and integrins are primarily involved in cell surface adhesion ([@B33]). Cadherins are present on the membranes of adjacent cells binding each other at the membranes ([@B46]). Among the catenins, β-catenin, which activates the Wnt signaling pathway ([@B142]), is involved in cellular adhesion, growth and differentiation and has been implicated in transition of normal cells to transformed/cancer cells ([@B213]). Anchoring or Adherens junctions are responsible for binding with the cytoskeleton thus imparting support as well as signaling hubs, which are important in regulating gene expression ([@B139]). Gap junctions help in communication of cells through a set of integral membrane proteins called connexins ([@B44]). Gap junctions help in transport/direct exchange of solutes and molecules between cells. Normal/proper functioning of gap junctions have been shown to play key roles in growth, development and tissue homeostasis ([@B85]; [@B136]). TJs serve as fortifications for the cell with restricted entry and the only possible transport in a normal functioning healthy cell through a TJ is *via* active transport ([@B11]). They are also responsible in maintaining/imparting cell polarity. However, with increasing knowledge on TJ biology, both structurally and functionally, their roles have been emphasized to be equally important in cellular signaling cascades with control over growth, development, and differentiation. TJs are formed mainly by occludins, claudins and junctional adhesion molecules (JAM) which will be discussed in more detail in this review ([@B62]). TJ proteins regulate several key signaling pathways in cancer, also indirectly as interacting partners ([@B15]). Dysregulation of cell junction adhesion has been shown to be heavily implicated in the process of epithelial mesenchymal transition (EMT) ([@B143]). The dysregulation of these junctional proteins is widely correlated in breast, prostate, ovarian, endometrial, lung, liver and colorectal carcinomas ([@B133]; [@B24]). In addition, the TJ proteins play a major role in maintaining the integrity of the intestinal epithelium and any change like gut inflammation results in the disruption of the intestinal epithelium as seen in inflammatory bowel disease (IBD), such as ulcerative colitis (UC) or Crohn's disease (CD). The disturbances in TJ epithelial barrier integrity by dysfunctions in intestinal epithelial cell (IEC)--intrinsic molecular circuits that control the homeostasis, renewal, and repair of IECs can also trigger IBD. The present review tries to bring out the connection between various junctional proteins and signaling pathways associated with inflammation and cancer, with major focus on cancer.

Components of Epithelial Junctions
==================================

The structural integrity and key barrier function of epithelia and endothelia is preserved through interactions involving TJs, AJs, desmosomes and gap junctions (Figure [1](#F1){ref-type="fig"}). AJs are typically formed between cells and play important roles in development and tissue homeostasis. Desmosomes mainly provide mechanical strength to the cell in conjunction with cytoskeleton. Desmosomes are not continuous and cannot prevent solute transport, instead they create a strong structural network that binds cells together throughout the tissue ([@B99]). In contrast, gap junctions are like bridges between two cells allowing passage of nutrients or solute etc. between them. Gap junctions are a family of transmembrane proteins, also called connexins, which play a key regulatory role in cell differentiation and growth. TJs are exclusively found in epithelium and endothelium and are specific to vertebrates. The dysregulation of TJs leads to altered barrier function resulting in changes in levels of inflammatory cytokines such as IFN-α, IFN-gamma, IL-6 and IL-1β as seen in inflammation associated diseases such as IBD, multiple sclerosis and cancer ([@B70]; [@B195]; [@B29]). Therefore, current strategies are being developed by clinicians and researchers to treat these diseases by targeting the compromised TJs. TJs in cancer and inflammation are the main focus of this review.

![Epithelial intercellular junctions. Schematic drawing of the epithelial junction in vertebrate cell. The tight junctions, adherens junctions and gap junctions are located in the apical most region of the cell while the desmosomes are located toward the basal regions.](fphys-09-01942-g001){#F1}

Tight Junctions
===============

Tight junctions define the extremes of the cell by demarcating the cells upper and lower regions thus conferring polarity to the cell (Figure [1](#F1){ref-type="fig"}). Claudins and occludins are the most important TJ proteins that control the vital function of the cells. Other TJ proteins such as cingulin, Pals1 (Proteins Associated with Lin Seven 1), MUPP1 (multi-PDZ domain protein 1), and ZO1, ZO-2, ZO-3 (Zona occludens) ([@B65]) are framework forming proteins connecting transmembrane proteins with the actin cytoskeleton. There are three different ZO-1 proteins with shared structural features, Src homology 3 (SH3) domain, guanylate kinase (GUK) domain and N-terminal region with 3PDZ domains. ZO proteins form the central network for protein interactions. The first PDZ domain of all ZO proteins associates directly with the C-termini of claudins and this association has been attributed to have central role in TJ assembly and function. Down-regulation of ZO proteins has been reported in several cancers such as decreased levels of ZO-1 leads to increased motility in pancreatic cancer ([@B51]). However, upregulation of ZO-1 expression in melanoma cells has also been reported ([@B180]). Abnormal TJs as a result of either inflammation, mutations or an aberrant signaling mechanism disturbs the proper cell functioning and consequently results in disease such as cancer and other abnormalities ([@B164]; [@B168]). Among the TJ proteins, claudins in cancer and inflammation will be the focus of this review.

Claudins: Backbone of Tight Junction Strands
============================================

Claudins are a group of transmembrane proteins which play a critical role, along with other TJ proteins, in the proper functioning of epithelial TJs. Most of the claudins share a common motif, -Y-V in the c-terminal region. There are 27 claudins discovered till date which can be classified as closed, selectively permeable based on their functions (Table [1](#T1){ref-type="table"}). The importance of the claudins lies in the fact that the TJs are mainly formed by claudins ([@B37]). Claudins 1, 3, 5, 11, 14, and 19 belong to closed group and are responsible for water tight stability of the cell. Claudins-10b, and 15 allow passage of cations, and claudins -10a and 17 allow anions while claudin-2 is permeable to both anions and water thus ensuring proper availability of water and ions for cellular functions to be effectively carried out ([@B66]). The claudins along with their elegant interaction with occludins can hold all the proteins of the cytoplasmic milieu ([@B197]). Owing to the above fact, improper functioning of the claudins have been shown to be responsible to several disease conditions like IBD ([@B104]), colorectal cancer (CRC) ([@B94]), UC ([@B95]) and in numerous additional cancers, including breast, gastric, pancreatic, prostate, and uterine (Table [1](#T1){ref-type="table"}). Similarly, mutations in TJ proteins result in abnormalities as seen in patients with familial hypercholanemia ([@B11]), ichthyosis, and neonatal sclerosing cholangitis (NISCH) syndrome ([@B68]). In NISCH syndrome, claudin-1 is lost leading to increased epithelial cell paracellular permeability. Claudins exhibit a variable expression pattern (Table [1](#T1){ref-type="table"}) in various cell types and tissues and their expression has been described to be important for membrane functions ([@B132]), for example, claudin-1 is ubiquitously expressed, while claudin-3 and 4 are restricted to developmental stages and specific cell types ([@B22]; [@B201]). In the gastrointestinal tract, claudins show a high degree of variability in expression in different segments. In colon cancer, claudin-1 was observed to be having transformative and metastatic potential ([@B50]) while claudin-2 overexpression has been shown to be associated with colon carcinogenesis ([@B49]).

###### 

Dysregulated claudins in various cancers, crosstalk and the outcome.

  Tight junction proteins *Claudins 1-20*   Type of cancer                                Mechanism of action and signaling molecules involved                                                                                                                                                 Reference
  ----------------------------------------- --------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------
  Claudin-1                                 Human Breast Cancer                           Overexpression *via* PDGFRB and cadherin -1 deregulation, resulting in deregulated miRNAs associated with tumor suppression                                                                          [@B127]
                                                                                          PKC/Claudin-1 signaling pathway involved. Can be controlled *via* inhibiting EMT and its related factors: ZEB1, ZO-1, Slug, Twist, MMP9                                                              [@B75]
                                            Human Malignant Glioma Cells                  Overexpression of Claudins-1, 2, 3, *via* miR-30A targeting SLUG, suppressing EMT and metastasis                                                                                                     [@B30]
                                                                                          Upregulation *via* miR-203, downregulating SLUG and Vimentin and upregulating ZOI, inhibiting invasion and migration                                                                                 [@B31]
                                            Hepatocellular carcinoma                      Inducing c-Abl-ERK signaling pathway                                                                                                                                                                 [@B183]
                                            Melanoma                                      Delocalization to cytosol, increasing MMP-2 and migration                                                                                                                                            [@B58]
                                            Colon cancer                                  Notch/Wnt-signaling activation, inhibition of goblet cell differentiation, inducing mucosal inflammation, promoting tumorigenesis                                                                    [@B155]
                                            Colorectal cancer                             Upregulation of Claudin-1 and occludin *via* phosphorylation of p38 and ERK 1/2                                                                                                                      [@B184]
                                            Gastric cancer                                Overexpressed Claudin-1 associated with β-catenin                                                                                                                                                    [@B76]
                                            Squamous cellular carcinoma/Solar Keratosis   Decreased expression and Claudin-2 overexpression resulted in leakier epithelial barrier function consequently damaging skin epithelial resistance                                                   [@B73]
                                                                                          Overexpression in OSCC patient samples associated with advanced clinical stage and invasiveness                                                                                                      [@B170]
                                            Pancreatic ductal adenocarcinoma              Claudin-1, zinc finger transcription factors, ZEB1/Snail induced expression via eEF-2K mediates cancer cell invasion and metastasis                                                                  [@B13]
  Claudin -2                                Breast cancer                                 Overexpression results breast cancer liver metastasis via promoting cancer cell adhesion to hepatocytes                                                                                              [@B188]
  Claudin-3                                 Lung adenocarcinoma                           EGF-activated MEK/ERK and PI3K-Akt pathways                                                                                                                                                          [@B214]
                                            Breast cancer                                 Overexpression and delocalization results in tight junction protein deregulation, promoting tumor progression                                                                                        [@B193]
  Claudin-4                                 Breast cancer                                 Overexpression increased cell proliferation/migration, reduces apoptotic rate, regulated by methylation status                                                                                       [@B124]
                                                                                          Claudin-4 associated with tumor aggressiveness and formation of vascular channels                                                                                                                    [@B41]
                                            Endometrial cancer                            Intracellular localization of Claudin-4 involved in signaling to and from the tight junctions                                                                                                        [@B40]
                                            Gastric cancer                                Associated with increased MMP-2 and -9 expression levels, enhancing cancer cell invasion                                                                                                             [@B78]
                                            Nasopharyngeal carcinoma                      Overexpression related to advanced stage                                                                                                                                                             [@B186]
  Claudin-5                                 Glioma                                        Downregulation associated with increasing permeability and ZO-1, occludin suppression                                                                                                                --
                                                                                          Downregulation of Claudin-5, ZO-1, occludin mediated by RUNX1 via overexpressed miR-18a, leading to increased permeability                                                                           [@B140]
                                                                                          Reduced Claudin-5, occludin, and ZO-1 expression via overexpression of miR-181a targeting KLF6, leading to increasing permeability                                                                   [@B122]
                                                                                          Claudin-5 and occludin downregulation mediated by NOS/NO/ZONAB, leading to enhanced permeability                                                                                                     [@B116]
  Claudin-6                                 Human adenocarcinoma gastric cancer           Overexpression leads to MMP-2 activation                                                                                                                                                             [@B194]
  Claudin-7                                 Non-small cell lung cancer                    Reduced expression leads to metastasis                                                                                                                                                               [@B100]
                                            Colon cancer                                  Forced expression in cancer cell lines induces MET, suppresses p-Src and MAPK/ERK1/2 via Rab 25 dependent manner inhibiting tumor growth                                                             [@B19]
  Claudin-8                                 Colorectal cancer                             Downregulation of Claudin- 8 is associated with tumorigenesis                                                                                                                                        [@B64]
                                            Renal oncocytoma                              Claudin-8 and 7 as potential diagnostic biomarkers                                                                                                                                                   [@B92]; [@B151]
  Claudin-9                                 Lung cancer                                   Claudin -9 overexpression is associated with overexpressed MMP-12, supporting tumor cell egression                                                                                                   [@B175]
                                            Pituitary oncocytoma                          Overexpression correlated with weak blood vascular endothelium, actin cytoskeleton reorganization, paracellular permeability                                                                         [@B74]
  Claudin-10                                Lung cancer                                   Increased expression of Claudin-10 is associated with the development of lung adenocarcinoma mediated by c-fos pathway                                                                               [@B215]
                                            Biliary Tract cancer                          Decreased expression is observed in intrahepatic bile duct cancer                                                                                                                                    [@B145]
  Claudin-11                                Hepatocellular carcinoma                      Inhibition via miR-99b targeting 3^′^ UTR of Claudin-11 mRNA is associated with metastasis                                                                                                           [@B207]
                                            Cancer-associated fibroblasts (CAF)           Claudin-11 and occludin overexpression is associated with CAF migration via TGF-β secretion                                                                                                          [@B86]
  Claudin 12                                Colorectal cancer                             Claudin-12 overexpression is associated with the progression                                                                                                                                         [@B64]
  Claudin-14                                Human hepatocellular carcinoma                Low expression observed in patient samples associated with advance stage and downregulated expression results in increased expression and nuclear localization of β-catenin                          [@B107]
  Claudin-15                                Malignant pleural mesothelioma                Overexpressed Claudin-15 serves as potential antiproliferative function                                                                                                                              [@B32]
                                            Colitis cancer                                Higher expression observed with colitis cancer                                                                                                                                                       [@B12]
                                            Colon cancer                                  Claudin-15 overexpression associated with MMP-2 and -9 activation suggesting invasive characteristics                                                                                                [@B190]
  Claudin-16                                Renal cell carcinoma                          Overexpressed Claudin-16 is associated with disrupted barrier function and cell adhesion in cancer cells                                                                                             [@B138]
  Claudin-17                                Gastric cancer                                Downregulated Claudin-17 is observed in gastric cancer tissue correlated with lymphatic metastasis                                                                                                   [@B60]
  Claudin-18                                Lung squamous cell carcinoma                  Reduced expression is found in patient samples. Claudin-18 overexpression results in suppression of cell cycle G1/2 phase via p21 increase and Cyclin D1 decrease resulting in inhibition of p-Akt   [@B7]
  Claudin-20                                Human Breast Cancer                           Expression results in reduced TER and no decrease in paracellular permeability. Claudin-20 overexpression displayed aggressive phenotype                                                             [@B134]

In a recent study in CRC patients, claudin-4 expression loss has been attributed to increased metastasis or enhanced invasiveness of tumors and was found to have a relation with distant metastasis ([@B185]). Overexpression of claudin-3 and -4 in ovarian cancer cells promotes cancer progression ([@B3]) in both mouse and human ovarian cancer xenografts model ([@B174]). Further, the role of claudin-4 in pro-angiogenic and enhanced motility in ovarian cancer was also demonstrated ([@B108]). Interestingly, claudins-3 and -4 have been shown to be tumor suppressors as well. Their overexpression decreases Wnt signaling, affects *E*-cadherin expression, and decreases *in vitro* cell migration and invasion. In ovarian cancer, downregulation of claudin-3/-4 promotes tumor growth and metastasis, while less expression of claudin-3/-4 along with claudin-7 results in high malignancy in breast cancer ([@B160]). On the other hand, high expression of claudin-4 suppresses invasion and metastasis in pancreatic cancer ([@B141]) while in gastric cancer cells similar inhibition is seen without affecting the cell growth ([@B102]). Low expression of claudin-6 supports invasiveness in breast cancer ([@B149]), while in gastric cancer cells less expression stimulates invasion, migration, and proliferation (50). Interestingly, claudin-7 functions both as tumor suppressor and promoter. In esophageal squamous cell carcinoma claudin-7 has been shown to enhance cell growth and metastasis ([@B114]). In CRC and ovarian cancer, claudin-7 overexpression promotes tumor formation and invasiveness ([@B84]; [@B42]). However, in colon cancer, the same claudin-7 was shown to be having tumor suppressor effect ([@B19]). Claudin-11, a major component of myelin in central nervous system, is possibly involved in growth and differentiation of oligodendrocytes ([@B192]). In addition, altered expression and localization of several TJ proteins can be detected during inflammation process. First and foremost, claudin-2 abundance increases in various inflammatory diseases, such as CD, UC and celiac disease ([@B72]; [@B212]). Functionally, this leads to a flux of cations and water via the paracellular pathway into the gut lumen, which gives rise to leak flux diarrhea (92). Also, for claudin-15 an increased expression has been reported in celiac disease ([@B169]). Occludin downregulation has been reported for CD, UC and collagenous colitis ([@B27]; [@B72]; [@B212]). In intestinal cell lines occludin knockdown has been shown to increase macromolecule permeability ([@B8]; [@B28]). Based on the above literature, the claudins seem to exist universally from normal tissues, hyperplastic conditions, benign neoplasms, and cancers with differential expression, and their loss or gain of function is linked to inflammation and several malignancies.

Cross-Talk of Claudins With Signaling Pathways in Cancer
========================================================

Tight junctions of both epithelial and endothelial cells are critical in regulating the permeability across the epithelia and the TJ complex is a hub for signaling pathways which governs the metastatic potential in several cancers. The role of claudins in TJ cancer signaling hasbeen well documented (Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}). Mitogen-activated protein kinase (MAPK) ([@B59]) or protein kinase C (PKC) ([@B146]) induced phosphorylation of claudin-1 and cyclic AMP (cAMP)-induced phosphorylation of claudin-5 ([@B81]) promotes the barrier function of TJs, while claudin-6 phosphorylation mediated by protein kinase A increases Mg^2+^ transport ([@B79]). In addition, claudin phosphorylation is linked to increased paracellular permeability ([@B206]). Though phosphorylation of claudins is necessary for the maintenance of their function but abnormal phosphorylation affects their aggregation and structural stability which could lead to impaired epithelial barrier function ([@B179]; [@B110]). Previously, researchers have demonstrated that during the course of colitis, the phosphorylation status of colonic claudins changes which may be related to the change in the intestinal barrier function and the same group has shown that cytokines play an important role in this process ([@B109]). The phosphorylation of claudins and the associated effects on their normal functions apparently resembles that of the changes in phosphorylation of molecules involved in signaling cascades. This gives us a notion that these two sets of molecules might be closely related in their origins and functions which in due course of evolution might have diversified roles. This would help us to develop common drug targeting strategies.

![Schematic/proposed signaling model in a cell during tumor formation. Aberrant change in signaling pathways result in the resistance of the normal cellular apoptosis and/or senescence in a cell which is destined to be a tumor cell. The anti-apoptotic proteins belonging to the bcl2 family are upregulated. The tight junction complex changes its course of normal function of selective permeability to unrestricted flow to various unintended solutes/growth/cytokine factors which may be responsible in up regulation of survival signaling pathways. The expression and/or phosphorylation of growth factor/cytokine receptors which promote cell growth are enhanced. The PI3-K/Akt pathway, which is a survival pathway, becomes activated along with the RAS-RAF-ERK pathway and Wnt/beta-catenin pathway which result in the up regulation of several growth response genes.](fphys-09-01942-g002){#F2}

![Schematic/proposed signaling model of role and regulation of claudins in a cell during invasive or metastatic stage. Deregulated claudin expression and delocalization occurs as a consequence of epigenetic factors, growth factors and cytokines, inducing loss of "gate and barrier" function and thereby promoting inflammation, EMT and disease progression. Once the cell is destined to be a tumor cell, it further becomes more aggressive. During this stage, the well-regulated junctional molecules between cells become more and more permissible to various factors responsible for the up regulation of the survival, rapid growth and proliferative signaling pathways. Also, the inhibitor for apoptosis (IAP) proteins, which are critical for inhibiting cancer cell death and promoting their survival, are also upregulated. Further, along with the PI3-K/Akt and RAS-RAF-ERK pathways, NOTCH pathway is also upregulated which further enhances the growth potential of the cancer cell. Further, tight junctional protein, such as claudin-1 is associated with beta-catenin and help in the enhanced translocation of beta catenin into the nucleus. At this stage both the NOTCH and the Wnt pathway act in co-ordination to enhance the metastatic potential of the cancer cell.](fphys-09-01942-g003){#F3}

![Schematic presentation of healthy and leaky gut. Epithelial tight junctions are intact in a healthy gut and selectively lets some molecules in and out of the intestinal epithelium by functioning as a seal between the neighboring gut cells, hence maintaining homeostasis. Factors such as proinflammatory mediators, microbial gut imbalance, infections, some foods, exposure to chemicals, toxins, or stress may disrupt epithelial tight junctions and increase the intestinal permeability, as well as possibly damage the intestinal barrier by forming tissue lesions and punctures that could lead to a leaky intestinal epithelium. This whole sequence of events may lead to the translocation of undesired luminal gut content (microorganisms, toxins, undigested food particles) into the host tissues activating an immunological response.](fphys-09-01942-g004){#F4}

Very recent studies on blood-brain barrier (BBB) alterations in Japanese encephalitis virus infection (JEV), increases the diverse relationship of TJ proteins and signaling pathways ([@B198]). It was shown that a decrease in claudin-5, ZO-1 and occludin was observed during JEV infection which were restored with the administration of neutralizing antibodies against IP-10, an abundant chemokine produced in the early stage of JEV infection, helping decrease the BBB damage. This study suggests a very important role for TJ proteins in maintaining BBB ([@B198]). More importantly, the authors found that the alteration in BBB permeability was due to the nexus between IP-10, TNF- α and c-Jun N-terminal kinase (JNK) pathway, giving another solid proof of cross-talk between TJ proteins, inflammatory cytokines and signaling networks. Another study, establishing the cross-talk between TJ proteins and key signaling pathways was demonstrated by [@B35], through blood vessel epicardial substance (BVES), or POPDC1, a TJ-associated transmembrane protein which has a key role in protecting colonic epithelial integrity ([@B35]). BVES modulates epithelial-to-mesenchymal transition (EMT) via junctional signaling pathways ([@B204]). While investigating its role in colitis, they observed a decrease in claudin-7 and increased ZO-1 protein expressions. While, a significant increase in claudin-2, JAM-A, and Zo-1 mRNA expression was observed. Moreover, they also observed an increase in phosophomyosin light chain 2 (pMLC), which is a key effector in RhoA signaling ([@B35]). Their studies demonstrated, several negatively affected TJ proteins with BVES deletion resulting in an increased colonic permeability. More interestingly, previous studies by [@B163] on BVES suggests an enhancing and suppressive effect on Notch and Wnt pathways respectively in BVES -/- mice. An interesting study by [@B89] on the exposure of ozone and TJ proteins turned out to be revealing us another tie up between TJ proteins and signaling pathways, the immune signaling networks. They examined primary human lung epithelial cells and mouse models to understand the relationship of TJ proteins in exposure to ozone conditions. In their study, they found that ozone exposure in mice increases TNF- α, IL-4, IL-18, and IL-1b levels along with seemingly concomitant increase in claudin-3, claudin-4ROS, Nrf2, and Keap1 protein expressions and decrease in the lung claudin-14 protein expression. These recent studies take us toward a more better realization of closely knit association between the TJ proteins and signaling circuits and warrants extensive studies on TJ proteins and signaling networks.

In light of the above studies on TJ proteins and signaling pathways in disease condition, leaves us no doubt that TJ proteins significantly affects the cellular processes. It would also be interesting to understand the modulations in TJ proteins in normal development, which is beyond the scope of present review.

Apoptotic Signaling: Tnf, Pi3K-Akt and Integrin Signaling
=========================================================

Resistance to anoikis results in anchorage-independent growth and EMT which are vital during cancer progression and metastatic colonization ([@B152]). Several mechanisms are involved in anoikis resistance of tumor cells of which integrin over-activation of receptors ([@B69]; [@B47]; [@B178]) along with appropriate changes in tumor microenvironment significantly contributes toward successful anoikis resistance. It has been observed that Akt, a signaling protein, plays a central role in anoikis resistance by decreasing the proapoptotic proteins, Bad and caspase-9, through its phosphorylation ([@B82]) and by upregulating anti-apoptotic protein, Bcl2 expression. Further, in response to integrin-mediated cell attachment, phosphatidylinositol- 3 kinase (PI3K) activates Akt that promotes cell survival ([@B93]). Overexpression of claudin-2 in tissue samples from CRC patients was shown to be correlated with cancer progression. A similar trend was also observed in IBD associated CRC tissues. It has been shown that overexpression of claudin-2 increased cell proliferation, anchorage-independent tumor growth in CRC cells *via* EGF receptor (EGFR)-dependent manner ([@B49]). In line with the above studies, Jose et al. group observed an increase in cell migration and anchorage-independent behavior of human colorectal adenocarcinoma (HT-29) cells in association with increased claudin-3 expression mediated by EGF *via* triggering ERK1/2 and PI3K-Akt pathways ([@B45]). [@B178] have found a novel link between claudin-1 and Src proteins involved in the regulation of anoikis in colon cancer cells through claudin-1/Src/PI3k-Akt/Bcl-2 dependent signaling. This association significantly stimulates the invasiveness and metastasis of colon cancer cells. All these studies support that interactions between claudins and Bcl-2 have a definitive role in tumor metastasis. However, it should not be overlooked that this interaction may be more specific in CRC. Over expression of claudin-1 in MCF-7 breast cancer cell line contributes to anti-apoptotic role under tumor necrosis factor (TNF)-α treatment while the knockdown of claudin-1 increases the susceptibility of MCF-7 cells to TNF-α-induced apoptosis ([@B117]). The findings by [@B161] attribute a pro-angiogenic role to JAM-C, while JAM-A was shown to be important in colon inflammation and proliferation of IEC by inhibiting Akt-dependent β-catenin activation ([@B144]). Both *in vivo* and *in vitro* studies have shown that the loss of JAM-A expression was associated with higher IEC proliferation ([@B144]). The same group demonstrated that the increased proliferation of IEC involves PI3K and phosphatase and tensin homolog (PTEN)-dependent Akt-mediated β-catenin transcriptional activation. Interestingly an association of loss of JAM-A expression with significantly altered/ or increased expression of claudin-10 and -15 ([@B96]), results in increased inflammation and paracellular permeability of the IEC. However, occludin or claudin-2 level was not altered in these cells, which hints toward a possible association of trigger to specific claudins.

These studies show how complex links could be made by TJ proteins with cell death pathways, growth and inflammatory responses. This encourages more studies centering TJ proteins with diverse signaling pathways.

Notch and Wnt Signaling
=======================

Notch signaling plays a key role in tumorigenesis either by activating or inhibiting cellular processes such as proliferation, differentiation, and apoptosis ([@B23]; [@B105]; [@B17]). In HCT 116 colon cancer cells, Notch represses the p53-dependent transactivation through the interaction of Notch1 with p53 which results in inhibition of p53 phosphorylation, and subsequent inactivation of p53-dependent apoptotic pathway ([@B91]). Notch and Wnt/β-catenin signaling is important for intestinal development and maintaining homeostasis ([@B5]). The Notch signaling is also important in determining intestinal epithelial renewal and their function ([@B56]). On the other hand, Wnt signaling pathway by regulating the cytoplasmic and nuclear β-catenin levels plays a crucial role during development of different tissues and organisms ([@B36]). Few reports have shown upregulated expression of Wnt target genes, c-myc, cyclin-D1, MMP-7, Tcf1, and EphB2, and Notch target gene hes1 in tumors ([@B196]; [@B166]). Moreover, lack of coordination between Notch and Wnt signaling was shown to be involved in enhancing inflammation or tumorigenesis ([@B57]; [@B5]). In CRC cell lines, claudin-1 expression enhances the tumorigenic ability and also leads to the mucosal inflammation *via* activation of Notch pathway, and further inhibits goblet cell differentiation ([@B155]). It has been observed that caudal-related homeobox (Cdx) transcription factors regulate claudin-1 gene expression in human colon cancer cells and functional crosstalk with Wnt-signaling pathway was found to be important for this regulation ([@B20]). In accordance with these studies, Notch-signaling was shown to be regulated by claudin-1 overexpression, which in turn increase the MMP-9 and p-ERK expression in transgenic mice resulting in metastasis of colon cancer and colonic epithelial homeostasis ([@B156]). Added to the growing complexity, it has been demonstrated recently that claudin-7 to be a tumor promoter, in colon and pancreatic cancer, through its association with epithelial cell adhesion/activating molecule (EpCAM) thereby promoting/inducing EMT ([@B153]). By disrupting the link between β-catenin and F-actin, EpCAM interferes with *E*-cadherin mediated cell-cell adhesion ([@B191]). It also has a role in Wnt/β-catenin signaling pathway ([@B205]; [@B112]), regulates PKC ([@B126]) and MMP-7 expression as well ([@B48]). It was shown that claudin-7 guides/recruits EpCAM toward signal transduction platforms or glycolipid-enriched membrane microdomains (GEM) where it becomes susceptible to digestion by TNF-α converting enzyme (TACE) releasing EpIC which acts as a cotranscription factor in cooperation with β-catenin and others ([@B153]). In addition, EpIC also contributes to EMT by upregulating vimentin, Snail, Slug and downregulating *E*-cadherin. Interestingly, Notch was also upregulated in holoclones, a colony-forming stem cells that have higher growth potential due to absence of differentiated cells ([@B55]). Moreover, FGF and TGFβ, known to upregulate EMT ([@B177]) were down-regulated in claudin-7 knockdown cells.

Activation of Wnt/β-catenin signaling pathway by Wnt ligands is involved in regulating embryonic development and homeostasis in later stages ([@B111]; [@B43]). Mislocalization of β-catenin and dysregulation of Wnt/β-catenin signaling pathway is shown to be associated with development of various cancers ([@B154]; [@B87]; [@B199]). In CRC, Wnt/β-catenin signaling becomes more important as greater than or nearly 70% of CRC tumors exhibit mutations in *adenomatous polyposis coli (APC)*, a Wnt pathway component. Interestingly nuclear localization of claudin-1, along with β-catenin, was observed in liver metastatic lesion samples ([@B50]) suggesting that claudin-1 may assist/promote the translocation of membranous β-catenin to enhance the activation of its target genes leading to robust growth and/or survival of the cancerous cells. These different important interactions of the TJ proteins with the signaling cascades suggests that TJ proteins might be having different binding specificities to different signaling molecules and that they are dependent in a contextual manner, which needs to be explored.

These studies establish an association of TJ proteins with well established growth and developmental pathways. However, it would be interesting to know about novel signaling mechanisms which may work independently or in association with established pathways keeping TJ proteins in the focus. These studies would open avenues for new strategies of treatment.

Kinase Signaling
================

It has been observed that manipulating claudin-1 expression results in phenotypic changes significantly effecting growth and metastasis of tumor xenograft in athymic mice ([@B50]). The same group observed that upregulation of claudin-1 enhanced the metastatic potential by altering the *E*-cadherin expression and Wnt/β-catenin signaling ([@B50]). Interestingly, increased claudin-1 expression in metastatic tissues was associated with its mislocalization from membrane to nucleus ([@B50]). Given the cross-talk between Wnt/β-catenin signaling and NF-κB in inducing inflammatory responses ([@B121]), it is possible that claudin-1 associated modulation in signaling may also result in inflammation associated changes. This would be an interesting area to explore in future. Also, in oral squamous cancer, claudin-1 upregulates MMP activity and promotes invasiveness ([@B52]). In melanoma as well, similar correlation was reported ([@B106]). In human liver cells, increased expression of claudin-1 both at mRNA and protein levels associated with PKC activation, which subsequently promotes invasiveness through stimulation of c-Abl-PKC signaling ([@B209]; [@B113]). Lin et al. have showed that absence of claudin-3 and claudin-4 enhanced the EMT activity in ovarian cancer cells through downregulating *E*-cadherin expression, upregulating Twist, and activating the PI3K pathway ([@B113]). As PI3K pathway is well evidenced to have roles in recruiting inflammatory immune cells, it may be plausible that claudin modulation has an indirect effect on inflammation as well ([@B71]). Claudin-1 promotes EMT in human liver cells, while claudin-3 and claudin-4 promote EMT in ovarian cancer cells, which suggests that the effect of claudins on EMT is tissue-specific ([@B209]). Phosphorylation is shown to be having a regulatory role in the function of claudin-3 and claudin-4, for example, activated PKA ([@B53]) or PKC ([@B54]) phosphorylates claudin-3 and claudin-4 and enhance the paracellular permeability in ovarian cancer cells through the mislocalization of claudins. In human pancreatic cancer cells, phosphorylated claudin-4 by PKC not only increase its mislocalization but also compromised the TJ barrier integrity ([@B103]). Studies have shown that the effects of claudin-3 and claudin-4 are more pronounced in ovarian cancer cells. The overexpression of claudin-3/-4 correlates to ovarian cancer progression with concomitant activation of MMP resulting in increased invasiveness ([@B3]). It was shown that claudin-3 inhibition with small interfering RNA reduced the growth and metastasis of ovarian cancer in xenografts model, which strongly supports the cancer-promoting role of claudin-3 ([@B77]). Both *in vitro* and *in vivo* studies in ovarian cancer observed that claudin-4 promotes the angiogenesis by inducing the production of angiogenic factors such as IL-8 ([@B108]), suggesting the pro-angiogenic role of claudin-4 in ovarian cancer. On the other hand, adherens were shown to be responsible in the altered expression of claudin-5. In this study, Andrea et al. showed the up regulation of claudin-5 gene by endothelial VE-cadherin (VEC), which transfers intracellular signals at AJs ([@B189]). This was achieved by inhibiting the β-catenin translocation to the nucleus or sequestering it from the nucleus and through Akt mediated inactivation of FOXO1 inhibitory activity ([@B189]). The treatment of the VEC-positive cells with glycogen synthase kinase 3 (GSK-3) β downregulated the claudin-5 expression. The β-catenin was also found to be directly associated with FOXO1 and that this association at the promoter region of claudin-5 is required for its regulation/overexpression ([@B189]). In the absence of VEC, the FOXO1--β-catenin--Tcf-4 complex binds to the promoter of the claudin-5 gene and inhibits its expression. In the light of these studies, it is evident that β-catenin pathway plays a central role in effecting signaling cascades and it also seems to be imperative that it might have influence in inflammation associated mechanism. Another interesting study observed that the co-localization of claudin-9 and -6 with AJs regulatory proteins in a heterologous system forms a novel TJ strand ([@B147]). However, this was carried out in normal inner ear cells; it would be interesting to investigate the existence of similar kind of associations in cancer cells and their relevance to cancer metastasis.

Erk Pathway
===========

ERK signaling is activated by diverse mechanisms which majorly includes ligation of receptor tyrosine kinases and cell adhesion receptors. Activated ERK can phosphorylate a wide range of substrates and thereby affecting a broad array of cellular functions including proliferation, survival, apoptosis, motility, transcription, metabolism and differentiation. In a recent study it was shown that MAPK/ERK1/2 pathway is involved in the regulation of TJ proteins in the mouse epididymis. The study reported that the reduction in ERK1/2 phosphorylation (pERK), is associated with the decrease in ZO-2 expression and increase in ZO-3 expression in TJs but had no effect on ZO-1 expression. In addition, it was shown to affect the redistribution of claudin-1 and claudin-4 at the membrane junctions without affecting claudin-3 ([@B88]). The contradictory role of ERK activation is more pronounced in TJ integrity where its activation leads to disruption of TJs in some epithelial monolayers and prevention in other epithelia. This interesting phenomenon was observed in Caco-2 cell monolayers by [@B4]. They observed that in under-differentiated Caco-2 cells, ERK is involved in the destabilization of TJs, whereas a protective role was observed in differentiated cells. They suggested that this differential effect is due the differences in the subcellular distribution of ERK and its ability to regulate the association of PKCζ and PP2A (protein phosphatase 2A) with TJ proteins ([@B4]). ERK signaling has also been shown to be activated by TJ proteins which in turn determines the fate of cell. Though claudin-7 contributes toward cell growth and metastasis of esophageal squamous cell carcinoma ([@B114]), in lung cancer it inhibits migration and invasion *via* ERK/MAPK signaling pathway. ERK/MAPK signaling pathway inhibited by claudin-7 caused reduced migration and invasion ability of non-small lung carcinoma cells ([@B119]). Interestingly, they observed stable complex formation, in co-immunoprecipitation studies, between claudin-7 and claudin-1 and -3 suggesting a cooperative relationship between claudins. Similar results were observed in CRC cells where overexpression of claudin-7 inhibited proliferation and invasion by regulating ERK and Src signaling ([@B19]). Another study by [@B183] showed that claudin-1 induces EMT in human liver cells, which largely depends on the activation of the c-Abl-Ras-Raf-1/ERK1/2 signaling pathway. This finding supports the importance of c-Abl-ERK signaling in claudin-1 associated malignant phenotype. In lung cancer A549 cell line, the increased expression of claudin-2 was associated with the activation of EGFR/MEK/ERK signaling pathway ([@B80]). It was further observed that c-Fos, a down-stream target in an EGFR/MEK/ERK pathway, upregulates the transcriptional activity of claudin-2 by interacting with the AP-1 binding site of claudin-2 promoter ([@B80]). Contradictory to ERK activation by claudin-2, [@B115] demonstrated that the ERK 1/2 signaling pathway is a negative regulator of claudin-2 expression in mammalian renal epithelial cells affecting TJ permeability and renal epithelial function. These studies give us an indication that the claudins are regulated in a tissue specific manner and they themselves regulate the signaling pathways in the same fashion.

In addition, TJ protein expression and localization changes during inflammation process are well reported. First and foremost, claudin-2 abundance increases in various inflammatory diseases, such as CD, UC and celiac disease (90, 89, 91). Functionally, this leads to a flux of cations and water via the paracellular pathway into the gut lumen, which gives rise to leak flux diarrhea (92). Also, for claudin-15 an increased expression has been reported in celiac disease (91). Occludin downregulation has been reported for CD, UC and collagenous colitis (90, 89, 96). In intestinal cell lines occludin knockdown has been shown to increase macromolecule permeability (98, 99). Based on the above literature, the claudins seem to exist universally from normal tissues, hyperplastic conditions, benign neoplasms, and cancers with differential expression, and their loss or gain of function is linked to inflammation and several malignancies.

In view of the importance of kinase signaling cascades in inflammation and cancer, and the above observed important associations of claudins and kinase pathways, it greatly widens the diverse roles of TJ proteins in smooth functioning of cellular processes. More studies are warranted to delve into the details of cross-talk between TJ proteins and signaling mechanisms not only in cancer but also in other diseases.

Tight Junction in Intestinal Inflammation and Functional Crosstalk With Signaling Pathways
==========================================================================================

As TJ barrier dysfunction and inflammation are tightly associated with each other, equally inflammation and cancer are closely linked ([@B38]; [@B162]; [@B98]). Whether barrier dysfunction is the underlying cause of inflammation or vice versa and if inflammation leads to cancer or vice versa, these are the concepts which need more visibility and discussion. From the literature, it seems that there exists a positive feedback loop which connects them together. In this section we will focus on TJ barrier dysfunction and inflammation and in the next section we will briefly describe the bridge between inflammation and cancer. It is well established that the dysfunction of TJ barrier under inflammatory conditions contributes to the pathogenesis of intestinal disease. Compromised TJ barrier increases paracellular permeability and triggers an array of events including apoptosis, erosion, and ulceration that contributes to intestinal epithelial damage ([@B211]; [@B72]; [@B172]). Influx of immune cells into the intestinal mucosa *via* disrupted TJ influences the epithelial function by stimulating the release of proinflammatory cytokines such as TNF-α and IFN-γ. Increased levels of TNF-α and IFN-γ in the mucosa of patients with IBD, contributes to the proinflammatory cascade, and in turn intestinal barrier disruption ([@B125]; [@B2]; [@B171]; [@B25]) (Figure [5](#F5){ref-type="fig"}). TJ in inflamed epithelia of the intestine is characterized by reduced TJ strands, strand breaks, and changes in TJ proteins composition and function. Mucosal inflammation affects the permeability of the gut barrier by altering the intestinal epithelial homeostasis that may impair the structure and remodeling of apical junctions. It is now clear that IBD can be triggered by disturbances in TJ barrier integrity via disturbances in IEC molecular machinery that controls the homeostasis, renewal, and repair of IECs. Although TJs are considered a part of the physical barrier, specialized IECs (IECs), such as goblet cells and Paneth cells, play an important role in antimicrobial defense, thus making them crucial to innate immune system. Goblet cells help to protect against invasive pathogens by secreting antimicrobial molecules, such as trefoil factors and mucins. Trefoil factors help in restoring the gastrointestinal mucosal homeostasis while mucin constitutes a thick mucus layer to prevent excessive direct contact of bacteria to the epithelial cell surface ([@B137]; [@B6]). Paneth cells are involved in the innate host defense by secreting high levels of antimicrobial peptides within the crypts of the small intestine ([@B14]; [@B97]). The induction of these antimicrobial peptides is profoundly related with the function of intestinal barriers and hence an association with the IBD ([@B90]). Previously, we have shown that claudin-1, most widely studied member of TJ protein family, helps regulate the intestinal epithelial homeostasis by regulating the Notch signaling ([@B156]). Increased claudin-1 expression activates Notch-signaling through stimulation of MMP-9 and p-ERK signaling pathway and the overall effect is inhibition of goblet cell differentiation ([@B156]). Active inflammatory areas have been shown to possess increased expression of claudin-1 which further contributes to disease severity ([@B202]). Claudin-3, -5, and -8, function as sealing TJ proteins, whose expression was diminished in patients with CD resulting in impaired TJ complexity, lower number of TJ strands and more strand breaks. These patients also have diminished levels of occludin and upregulated level of pore forming claudin-2 expressed in the ileum of both quiescent and active CD. In addition, colonic biopsies from CD patients showed the mislocalization of claudin-2 contributing to the disrupted TJs. However, other studies have reported increased claudin-12 not claudin-2 expression in ileum of CD patients, the contradictory decreased claudin -2 expression in the sigmoid colon ([@B104]). Not only the expression but also the distribution of TJ proteins is affected in inflamed intestinal mucosa as observed with claudin-5 and -8 in the TJ of CD ([@B212]). In case of UC, similar changes in TJ proteins were observed including decreased expression of occludin, claudin-1 and claudin-4 and up-regulation of the pore-forming claudin-2 ([@B72]). Increased claudin-2 expression both at protein and transcriptional levels was found to be correlated with disease severity in UC ([@B72]). Additionally, extrajunctional mislocalization of claudin -4 and reduced staining intensity on surface epithelium for claudins- 3, 4, and 7 has been shown in UC ([@B159]; [@B150]). Additional TJ proteins that were upregulated in UC includes claudin-12 and claudin- 18, however, the elevated claudin -18 expression was not associated with the severity of inflammation indicating a primary defect in barrier function ([@B217]; [@B104]).

![Schematic representation of claudin interaction with adhesion molecules and signaling proteins. Claudins and claudin containing complexes influence diverse signaling processes within cancer cells that results in altered migration, invasion and metastasis. Claudins either interact directly with other adhesion molecules or recruit signaling proteins to execute their diverse array of functions.](fphys-09-01942-g005){#F5}

Increased or abnormal expression of proinflammatory cytokines contributes to the barrier defects in IBD. Patients with IBD, such as UC and CD, are at increased risk of developing CRC, confirming that chronic inflammation predisposes to development of tumors. CRC therefore represents a paradigm for the link between inflammation and cancer. Inflammation is driven by soluble factors, cytokines and chemokines, which can be produced by tumor cells themselves or, more often, by the cells recruited to the tumor microenvironment. Inflammatory cytokines and chemokines promote growth of tumor cells, perturb their differentiation, and support the survival of cancer cells. In CD, the levels of TNF-α and IFN-γ are increased favoring Th1 profile while the inflammatory response in UC is attributed to increased levels of TNF-α and IL-13. Cell culture and animal studies have clearly shown that these proinflammatory cytokines induce changes in TJ proteins, induction of apoptosis and enhanced bacterial translocation as observed both in CD and UC ([@B83]). Cytokines affect TJs by regulating the expression and redistribution pattern of proteins. Claudin-2 protein expression was found to be increased in HT-29/B6 cells when treated with TNF-α and IL-13 via the phosphatidylinositol-3-kinase pathway ([@B128]). Native rat colon when exposed to TNF-α and IFN-γ showed increased expression of pore forming claudin-2 and down regulation of barrier forming claudin-1, -5 and -7 ([@B10]). Colonic epithelial cells exposed to TNF-α have shown redistribution of ZO-1 from the cell membrane along with increased paracellular permeability and decreased TER ([@B171]). The changes in TJ structure and the expression of its component proteins on exposure to TNF-α are mediated *via* NF-kB signaling ([@B181]; [@B123]). Both human IBD and experimental models of intestinal inflammation showed similar structural and functional changes in TJ ([@B171]; [@B157]; [@B158]), which were largely associated with decreased key TJ proteins including ZO-1 and occludin. Colonic inflammation mice model generated using the dextran sulfate sodium (DSS) showed decreased ZO-1 along with consecutive increase in claudin-1 expression ([@B157]). Similar increase in claudin-1 expression was observed in IEC-18 cells when exposed to TNF-α and in the patient samples of UC ([@B158]). Our study on HT29 cells also showed that TNF-α regulates claudin-1 expression and localization via activation of ERK1/2 and Src signaling ([@B18]). IL6, one of the major proinflammatory cytokine mainly produced by epithelial cells and immune cells of the lamina propria has been shown to induce claudin-2 expression through MEK/ERK, PI3K signaling pathways, and transcriptional factor Cdx2 expression ([@B187]). The dynamic nature, composite signaling environment and the sensitive balance between proliferation and cell shedding of the intestinal epithelium provides great potential of disturbances and an interesting area of research. This whole set of proliferation and physiologic epithelial cell shedding involves rearrangement of TJ proteins to extrude the cell from the epithelium ([@B135]). The integrity of TJs is firmly regulated by TJ proteins and Myosin light chain kinase (MLCK), an important regulatory element, is found to be deregulated in the intestine of IBD patients ([@B21]). Phosphorylation of MLCK results in F-actin reorganization and consequently TJ protein redistribution to intracellular compartments form the apical domain of the enterocyte ([@B176]) and ZO-1 exchange was suggested to be critical for this process ([@B210]). In addition, MLCK activation results in increased claudin-2 expression by stimulating IL-13 synthesis ([@B203]). In Caco2 cells, MLCK gene expression is stimulated by TNF-*α* and interleukin-1*β via* NF*κ*B resulting in enhanced TJ permeability ([@B208]; [@B9]). Therefore, inhibiting the TNF-α induced MLCK expression can restore the function of TJ barrier. Mice with experimental colitis had increased expression of MLCK, resulting dysregulation of TJs and a severe loss of epithelial barrier function ([@B182]). Studies have also shown that MLCK-induced caveolin-1-dependent endocytosis of occludin is important for regulation of TJ structure and function ([@B130]). In contrast, the TJ redistribution induced by IFN-*γ* was found to be *via* Rho/ROCK signaling-dependent macropinocytosis-like mechanism ([@B26]). Rho-A is also vital to epithelial integrity and Rho-A signaling has been shown to be impaired in IBD patients because of the reduced expression of the Rho-A prenylation enzyme geranylgeranyltransferase-I ([@B118]). Mice lacking either Rho-A or geranylgeranyltransferase-I in IECs suffered from chronic intestinal inflammation, cytoskeleton rearrangement, and aberrant cell shedding. Another important molecule involved in regulated cell shedding and epithelial integrity is Rho associated kinase, which is a downstream effector of Rho-A and plays vital role in signal transduction pathways that control adhesion, transmigration, phagocytosis, and proliferation ([@B16]; [@B216]; [@B101]). Rho-associated kinase was found to be highly activated in the inflamed intestinal mucosa of patients with CD, suggesting impaired cytoskeletal rearrangements ([@B173]).

In summary, the regulated tissue specific expression of TJ proteins and their crosstalk with signaling pathways both at membrane and within the cell determines distinct functions of the small and large segments of the healthy intestine. In IBD, TJ proteins change in expression and localization which causes segment-specific alterations in paracellular barrier and channel functions. These changes generally result in increased paracellular transport of solutes and water, typically mediated by up-regulated claudin-2 and down-regulated barrier forming claudins. This whole process leads to diffusion of ions and water from blood to lumen, causing leak-flux diarrhea. The other possibility is the increased permeability to large molecules including luminal pathogens which may initiate an immune response and cause inflammation. The significant contribution of claudins in different inflammatory processes and diseases and in the recruitment of signaling molecules brands them appropriate for therapeutic intervention.

Bridging Inflammation and Inflammation Associated Colorectal Cancer
===================================================================

Inflammation and cancer are closely connected. Inflammation can contribute from initiation of the malignant phenotype to metastatic spread in different ways but usually requires a switch from acute to chronic inflammation ([@B38]; [@B162]). Inflammatory cells generate reactive oxygen species and proinflammatory mediators which may enhance the mutation rate of cells, induce DNA damage and increase genomic instability ([@B200]). These reactive species may also inactivate mismatch repair functions, supporting tumor initiation. In a positive feedback loop, DNA damage can also lead to inflammation, supporting tumor progression ([@B148]). Inflammation surges the risk of developing many types of cancer (including bladder, cervical, gastric, intestinal, oesophageal, ovarian, prostate and thyroid cancer) but here we will briefly review IBD associated CRC as this falls within the scope of manuscript. It is well known that patients with IBD are at higher risk of CRC. Many evidences suggest a link between inflammation and CRC ([@B165]; [@B167]). There is a growing evidence that supports the role of immune cells, inflammatory cells, chemokines, cytokines and proinflammatory mediators in the pathogenesis of IBD associated CRC ([@B131]; [@B120]). Inflammatory cells and mediators support the cancer growth and progression by different means which includes (1) production of ROS and RNI, both are mutagenic; (2) by supporting neo-angiogenesis, and (3) by supporting metastatic spread through the induction of EMT ([@B63]; [@B67]). The proinflammatory pathways that are involved in these processes and provide a mechanistic link between inflammation and cancer include but not limited to, NF-*κ*B, TNF-α, IL-6/STAT3, cyclooxygenase-2 (COX-2)/PGE~2~, and IL-23/Th17 ([@B39]; [@B162]). The above literature besides providing a link between cancer and inflammation, also suggests the importance of the epithelial cell junctions in maintaining the integrity of the intestinal epithelium. Inflammatory cytokine mediated or any other disruption to the epithelial cell junctions results in chronic intestinal inflammation predisposing to the development of tumors.

The detailed knowledge and understanding of the mechanisms that associate IBD with CRC may provide concrete benefits both in the scientific and clinical facets related to the introduction of innovative diagnostic and therapeutic measures in patients with chronic inflammations.

Conclusion
==========

Tight junctions have emerged as dynamic bidirectional signaling hubs which host diverse regulatory mechanisms for appropriate junction assembly and function. TJ proteins signal to the cell interior either directly or through recruiting other signaling molecules to regulate cell proliferation, migration, survival and differentiation. Several cancers and inflammatory disorders have altered expression of TJ proteins especially claudin family members, making them attractive diagnostic and prognostic markers. The functional importance of claudins in cancer progression and other inflammatory diseases is well recognized, however, the mechanisms that drive these disease processes remain poorly understood. We are still in the preliminary phase to understand the interaction between junctional membrane proteins and these signaling mechanisms. We are gradually learning how this interaction affects junctional functions on one hand, and how, on the other hand, the junctional adhesion proteins use these mechanisms to signal to the cell interior. Most of these mechanisms have been studied in isolation and, therefore, it is not clear how distinct signaling mechanisms cooperate and influence one another, and how they are triggered in response to diverse stimuli. To understand these processes is of significant biological importance in terms of pathological relevance as junction assembly is disturbed in many common diseases, including acute and chronic inflammations and different types of cancer. The large number of pathogenic viruses and bacteria that interact with TJ components are thus of great interest, as they provide excellent experimental tools to expound how the deregulation of junctional signaling mechanisms contributes to disease development. Therefore, more studies are warranted in this direction and thus the development of claudin-targeted therapeutics represents a promising endeavor.
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